Cumulus Neuroscience Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cumulus Neuroscience Limited - overview
Established
2015
Location
Belfast, -, UK
Primary Industry
Medical Devices & Equipment
About
Founded in 2015 and based in Belfast, UK, Cumulus Neuroscience Limited, formerly known as BrainWaveBank Limited, operates as a developer of wearable electroencephalography medical devices that help track and assess brain activity for patients with dementia and other neurological disorders. In 2020, the company was renamed Cumulus Neuroscience due to the combination of BrainWaveBank with additional new technologies to create a single, integrated platform. As of 2024, the company is headed by its CEO Aman H. Bhatti.
In July 2025, Cumulus Neuroscience raised GBP 3. 25 million in venture funding led by new investor WhiteRock Capital Partners, with participation from other new investor Investment Fund for Northern Ireland. Returning investors ACF Investors and Clarendon Fund Managers also participated in the round. Cumulus Neuroscience provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients.
This addresses the significant unmet need for faster, more robust, and cost-effective execution and evaluation of clinical trials in neuroscience. The company plans to utilize the July 2025 funding to enhance its marketing initiatives, grow the commercialization team, and recruit essential positions.
Current Investors
Invest Northern Ireland, ACF Investors, Innovate UK
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Healthcare IT, Diagnostic Equipment, Medical Software, Gaming, Analytics & Performance Software
Website
www.cumulusneuro.com
Verticals
Artificial Intelligence, Cloud Computing, Mobile Apps, Wearables & Quantified Self
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Cumulus Neuroscience Limited - timeline of key events
Cumulus Neuroscience Limited - financials
| Fiscal Year Ended | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
Cumulus Neuroscience Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.